Analysis of the cumulative effect of schizophrenia-related single nucleotide polymorphisms

Roberto Lozano1 Pharmacy Department, Hospital Real de Nuestra Señora de Gracia, Zaragoza, SpainCorrespondence[email protected]

Reyes Marín2 Psychiatry Department, Hospital Real de Nuestra Señora de Gracia, Zaragoza, Spain

Isabel Freire2 Psychiatry Department, Hospital Real de Nuestra Señora de Gracia, Zaragoza, Spain

María-Jesús Santacruz2 Psychiatry Department, Hospital Real de Nuestra Señora de Gracia, Zaragoza, Spain

Asunción Pascual-García2 Psychiatry Department, Hospital Real de Nuestra Señora de Gracia, Zaragoza, Spain

References

NeedACGeDWealeMEA genome-wide investigation of SNPs and CNVs in schizophreniaPLoS Genet200952e100037319197363
PubMed Web of Science ®Google Scholar
WatsonJDBakerTABellSPGannALevineMOosickRMolecular Biology of the GeneSan Francisco, CAPearson PLC2008522
Google Scholar
PerkinsDOJeffriesCSullivanPExpanding the ‘central dogma’: the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophreniaMol Psychiatry2005101697815381925
PubMed Web of Science ®Google Scholar
HutchinsonMRNorthcuttALHiranitaTOpioid activation of toll-like receptor 4 contributes to drug reinforcementJ Neurosci20123233111871120022895704
PubMed Web of Science ®Google Scholar
LiuW1ChenEZhaoXWThe scaffolding protein synapse-associated protein 97 is required for enhanced signaling through isotype-switched IgG memory B cell receptorsSci Signal20125235ra5422855505
PubMed Web of Science ®Google Scholar
BundoMToyoshimaMOkadaYIncreased l1 retrotransposition in the neuronal genome in schizophreniaNeuron201481230631324389010
PubMed Web of Science ®Google Scholar
KaalundSSNewburnENYeTContrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brainMol Psychiatry12102013 [Epub ahead of print]
Web of Science ®Google Scholar